Background Mechanisms and electropharmacological characteristics in adult patients with atrial tachycardia (AT) are not well described. We proposed that a combination of electropharmacological characteristics, recording of monophasic action potential, and effects of radiofrequency ablation could further determine the mechanisms and achieve a new classification in adults with various types of AT 
Background Mechanisms and electropharmacological characteristics in adult patients with atrial tachycardia (AT) are not well described. We proposed that a combination of electropharmacological characteristics, recording of monophasic action potential, and effects of radiofrequency ablation could further determine the mechanisms and achieve a new classification in adults with various types of AT because they were important in regard to the correlation between mechanisms and pathophysiology, clinical syndrome, and responses to specific pharmacological or nonpharmacological therapies.
Methods and Results Thirty-six patients (11 female, 25 male; mean age, 57+13 years) with AT were referred for electropharmacological studies and radiofrequency ablation. Resetting response pattern, entrainment phenomenon, recording of monophasic action potential, serial drug test, response to Valsalva maneuver, endocardial mapping technique, and radiofrequency ablation were performed. Seven patients had automatic AT provocable with isoproterenol; neither initiation nor termination was related to programmed electri-A trial tachycardia (AT) has been well described in pediatric patients.1-3 However, differences in electrophysiological and pharmacological characteristics between children and adults with AT are not clear. AT does not require atrioventricular (AV) node or ventricular tissue for initiation; it is different from atrial flutter, atrial fibrillation, and sinoatrial reentrant tachycardia.4-13 The possible mechanisms of AT have been presumed to include reentry, abnormal automaticity, and triggered activity."2'4243 Reentry is usually confirmed by demonstrating initiation and termination of AT with programmed electrical stimulation and by presence of manifest or concealed entrainment; it is associated with anatomic or functional regions of block as well as areas of slow conduction.57 '8-13 Abnormal automaticity cannot be initiated or terminated with programmed electrical stimulation, and it is usually provocable after administration of intravenous isoproterenol.12 Tachycardia related to nonreentrant, nonau tomatic mechanisms (probably triggered activity) has not been well defined.14-17 Although the response to programmed stimulation (resetting phenomenon) is not a specific test for mechanisms of arrhythmia, entrainment could be demonstrated only in patients with tachycardia caused by reentry.1"'0'16-18 It seems possible that a monophasic action potential catheter could help record the delayed afterdepolarization from atrial tissues with triggered activity.19 '20 See page 1576
Pharmacological manipulation (including adenosine, acetylcholine, verapamil, propranolol, and isoproterenol) suggested diverse potential mechanisms of ventricular tachycardia. 21, 22 However, the basic electrophysiological characteristics of atrial and ventricular tissues were different, and the serial drug tests had not previously been performed in adult patients with AT. Basic electrophysiological studies from our laboratory on human atrial fibers found that exogenous adenosine and acetylcholine had similar effects23-25 and exerted their effects on myocardium (inhibition of adenylate cyclase) by binding to their receptors, which are coupled to a pertussis toxin-sensitive inhibitory, guanine nucleotidebinding (Gi) protein. 26 '27 However, a complex reflex sequence (both sympathetic and parasympathetic) induced by adenosine and Valsalva maneuver might affect tachycardia. [28] [29] [30] It was postulated that the mechanism of AT could be further elucidated by dipyridamole, 31, 32 edrophonium, and competitive adenosine A, and muscarinic cholinergic receptor antagonists (aminophylline and atropine, respectively). /3-Adrenergic blockade has been shown to be specifically effective in suppressing catecholamine-sensitive tachycardia, and verapamil is effective in AV reentrant tachycardia and ventricular tachycardia related to triggered activity.12,2'-23,34, 35 The roles of both drugs in the treatment of AT have not been well defined.
Radiofrequency catheter ablation of AT has been reported before. '3,36-38 However, comparative studies of radiofrequency ablation of various ATs in adults have not been performed. Application of radiofrequency energy to a critical area, resulting in termination of AT and prevention of its recurrence, would confirm that a critical myocardial focus is responsible for AT. Furthermore, a successful outcome would help establish the concept of accurate mapping of AT. Using a combination of electrophysiological characteristics, pharmacological response, and effects of radiofrequency ablation to further determine the mechanism and produce a new classification in adult patients with various types of AT is important, because these mechanisms correlate with pathophysiology, clinical syndromes, and response to specific pharmacological or nonpharmacological therapies.
Methods Patient Population
Thirty-six consecutive patients (11 women and 25 men; mean age, 57±13 years) with AT were referred to this institution for electrophysiological study and treatment of tachycardia by radiofrequency catheter ablation from November 1990 to October 1993. The procedure was performed prospectively under a protocol approved by the Clinical Investigation Committee. None of the 36 patients had previously undergone diagnostic electrophysiological study. The histories of AT ranged from 2 to 18 years (mean, 3+±-1 years). Tachycardia was incessant in 3 patients and intermittent in the remainder. Five patients had cardiomyopathy, 1 had biatrial enlargement identifiable by echocardiography, 4 had hypertension, 1 had coronary artery disease, 1 had congenital aortic stenosis, 1 had dextrocardia, and 3 had other associated tachycardias. All patients had multiple ECG recordings of tachycardia before referral (Table 1) .
Electrophysiological and Pharmacological Study Baseline Electrophysiological Study As described previously,13'39 the patients were studied in the postabsorptive, nonsedated state. Antiarrhythmic drugs were discontinued for at least five half-lives in all patients. Three multipolar, tip-deflectable, closely spaced (2 mm) electrode catheters (Mansfield, Boston Scientific) were positioned in the right atrium, His-bundle area, and right ventricle; and two orthogonal electrode catheters (Mansfield) were positioned in the coronary sinus for recording and/or stimulation. Three surface leads (I, II, and V,) were recorded simultaneously with intracavitary electrograms using a VR-13 recorder (Electronics for Medicine) at a paper speed of 100 to 150 mm/s and filtered between 30 and 500 Hz. Electrical stimulation was delivered by a programmable stimulator (DTU-215, Bloom Associates, Ltd) with a pulse duration of 2 milliseconds at approximately twice the diastolic threshold. Baseline electrophysiological study consisted of measurement of conduction intervals, followed by determination of atrial and AV node refractory periods (coupling intervals decreasing by 10-millisecond intervals). Rapid right atrial stimulation (paced cycle length from 600 milliseconds to 2:1 capture was noted) and right atrial extrastimuli (single and/or double) were used for induction and termination of AT, and they were repeated two to four times to ensure reproducibility of the responses. If programmed electrical stimulation failed to induce AT, isoproterenol (at graded dosages from 1 to 4 gg/min) or atropine (0.01 mg/kg) was infused intravenously until AT emerged or the sinus cycle length was accelerated to 400 milliseconds. After the initiation of AT, atrial extrastimuli (single or double) or rapid atrial pacing was delivered to terminate AT. Electrophysiological criteria used for diagnosis of AT included the following: (1) P-wave configuration different from that of sinus rhythm and atrial activation sequence supporting a nonsinus origin for initial depolarization; (2) tachycardia induction and maintenance independent of AV node conduction; and (3) excluding accessory pathways, AV nodal reentry, sinoatrial reentrant tachycardia, and atrial flutter (cycle length <280 milliseconds) as diagnostic possibilities.124-13 Detailed attention was given to the 12-lead ECG of any AT to determine similarity to the previously documented clinical tachycardia.
Resetting Response Study
To assess resetting response patterns, a single atrial extrastimulus was synchronized to the atrial activation wave and was delivered at the high lateral right atrium during AT in 10-millisecond decrements (beginning at 10 milliseconds less than the cycle length of AT, until the entire cardiac cycle was scanned, local atrial refractoriness was reached, or AT was terminated). Each coupled single atrial extrastimulus was delivered after every eighth beat with stable cycle length and was repeated two to four times to ensure reproducibility of the response.'3 Resetting of the AT was said to have occurred if (1) a less than compensatory pause occurred after a single extrastimulus as measured at the stimulation site with >20-millisecond advancement of the AT cycle and (2) the same AT (identical cycle length and morphology) resumed after the extrastimulus, suggesting a fixed exit site from the tachycardia circuit. For each AT, the difference between the longest and shortest coupling interval that resulted in resetting was defined as the resetting interval. The return cycle was defined as the interval from the last stimulated electrogram to the next electrogram measured at the stimulation site. Measurements were made from the rapid deflection of the local electrograms recorded from the proximal pair of the quadripolar electrode catheter.'3 Resetting response patterns were characterized by plotting the return cycles versus the coupling intervals of the extrastimuli. The responses observed could be grouped into three patterns. A flat pattern was defined by the presence of a .10-millisecond difference in return cycle occurring over a .30-millisecond range of coupling intervals. An increasing pattern was defined as an increase in the return cycle as the coupling interval of the extrastimulus was decreased. There were tachycardias meeting the criteria for a flat response at long coupling intervals followed by an increasing response at shorter coupling intervals; such a pattern was defined as mixed or "flat plus increasing" (Fig 1) .
Endocardial Mapping and Entrainment Study
Endocardial mapping studies were done at the same time as the baseline electrophysiological study. After the diagnosis of AT was established with a uniform P-wave configuration and stable cycle length, a 7F quadripolar electrode catheter with 2-mm interelectrode spacing (deflectable, 4-mm-tipped; Mansfield, Inc) was inserted into the right atrium via the right femoral vein for mapping and ablation. By use of biplane fluoroscopy (right and left anterior oblique views), the right atrial endocardium was mapped by rotation of the mapping catheter in the anteromedial, anterior, anterolateral, lateral, posterolateral, posterior, posteromedial, and septal positions at several levels, beginning high near the superior vena cava and then withdrawing 1 cm at a time to the inferior vena cava (ie, high, -1, -2, and -3 cm). Recordings from two or three sites near the right atrial appendage, the fossa ovalis, and 
Pharmacological Study
Drugs for terminating AT were administered after sustained AT (duration >4 minutes) was established. Electrophysiological study was performed before and after administration of each drug. Dipyridamole (0.56 mg/kg IV) was infused over a period of 4 minutes, followed by a continuous infusion of 5
,tg * kg`min-', and it was infused only when systolic blood pressure during AT was >90 mm Hg. Aminophylline (2.8 mg/kg IV) was selectively evaluated during concurrent infusion of dipyridamole. The total dose of aminophylline was delivered over 3 to 10 minutes. The dosage of intravenous verapamil was 0.15 mg/kg body wt over a period of 2 minutes as a loading dose followed by continuous infusion at 0.005 mg * kg body wt-1. min`. The dosage of intravenous propranolol was chosen to achieve significant ,3-adrenergic blockade: 0.2 mg/kg body wt at an infusion rate of 1 mg/min. For edrophonium, an initial injection of 2 mg was given over a period of 30 seconds, and an additional 8 mg was administered about 60 seconds later. If the AT was sensitive to edrophonium, the effect of muscarinic cholinergic receptor blockade with atropine (0.04 mg/kg IV) was evaluated. An intravenous bolus of adenosine was given over a period of 2 seconds, followed by saline flush; each dose of 15, 30, 60, 120, and 240 ,ug/kg was separated by at least 4 minutes, and the minimal dose and time required to terminate AT were recorded. Termination of AT by Valsalva maneuver or carotid sinus pressure (left or right side) was also performed. Other antiarrhythmic agents irrelevant to the present study were not used. Briefly, electropharmacological studies in the morning of the first day included baseline electrophysiological study, endocardial mapping, resetting and entrainment study, recording of monophasic action potentials, drug test (adenosine, edrophonium, and atropine), and Valsalva maneuver. After the above procedures, all the electrode catheters were removed and only one sheath with side arm was left in the jugular vein. Four hours later, drug tests with dipyridamole followed by aminophylline (reversal of persantin effect) were again performed in the laboratory. In the afternoon of days 3 and 5, drug tests with verapamil and propranolol, respectively, were performed (the electrode catheter for programmed stimulation was inserted from the sheath left in the jugular vein). Radiofrequency ablation was performed in the afternoon of day 7, and multiple electrode catheters were inserted.
Classification of Possible Mechanisms ofAT
Results of basic electrophysiological studies were difficult to extrapolate to explain findings in intact human hearts, and clinical electrophysiological study techniques had practical limitations in definitely differentiating reentry, automaticity, and triggered activity related to afterdepolarization. In this A B study, the major criteria of classification were according to whether (1) automatic AT could be initiated only by isoproterenol; (2) AT related to reentry or triggered activity could be initiated or terminated by programmed electrical stimuli; (3) only AT related to triggered activity had early or delayed afterdepolarization recorded in the monophasic action potential; and (4) only AT related to reentry had entrainment phenomenon during atrial pacing. The characteristics of each group are described in the "Results" section.
Radiofrequency Ablation of AT As described previously,13'39 radiofrequency ablation was performed with a radiofrequency generator (Radionics-3C, Radionics, Inc) providing 500-kHz, unmodulated sine-wave energy, connected to the distal 4-mm tip of the mapping/ ablation catheter (Mansfield, Boston Scientific) via a switch box and grounded to the patient's posterior chest wall with a standard electrosurgical grounding pad. Applied voltage and measured current were displayed continuously, and impedance was monitored by a meter on the radiofrequency generator. Radiofrequency energy was applied in a power range from 20 to 40 W, commencing with constant rhythm monitoring. The presumed ablation site was identified by several methods: concealed entrainment pace mapping and earliest atrial activation in patients with reentrant AT and pace mapping and earliest atrial activation in patients with automatic and triggered AT. If AT was terminated within 15 seconds after energy application (test pulse), a full 60-second application (long pulse) was delivered at that site. Radiofrequency discharge was terminated immediately on the occurrence of impedance rise, displacement of catheter, or a patient complaint of severe chest pain. If an ablation attempt at a particular site was unsuccessful in terminating AT within 15 seconds, radiofrequency discharge was terminated. Endocardial mapping was repeated in an attempt to identify a more accurate ablation site by systematically repositioning the ablation catheter several millimeters around the initial position. If a second AT focus was found, procedures including electropharmacological study, endocardial mapping, and radiofrequency ablation were repeated.
After successful ablation of AT, programmed stimulation was performed immediately and after ---20 to 30 minutes to determine whether AT was inducible. For the prevention of possible recurrence of tachycardia, a long pulse (60 seconds) of radiofrequency energy was delivered to the successful ablation site. Isoproterenol (2 to 4 ,g/min) was routinely used to facilitate induction after initial success. After completion of the study, patients were monitored in the coronary care unit overnight.
All patients had regular follow-up and did not take any antiarrhythmic drugs. They were seen in the outpatient clinic at 1 week, 1 month, and then every 3 months. A history of recent symptoms was taken. Physical examination, 12 
Results
Electropharmacological Characteristics Group 1: Reentrant AT Twenty patients had reentrant AT, and 7 (35%) of them had double AT (none of the group 2 and 3 patients had multiple AT) (see Tables 1 and 2 19 of the 27 (70%) were still inducible under dipyridamole. Aminophylline reversed the effects of dipyridamole, and AT was reinitiated in 7 of the 7 patients who were responsive to dipyridamole; (7) propranolol terminated 13 of 27 cases of AT (48%), and AT was still inducible under propranolol in 27 cases (9 with nonsustained AT, and 8 of the 18 [44%] with sustained AT had prolongation of AT cycle length) ( Fig  3C) ; clinical information showed that only 4 patients had good response to oral propranolol (80 to 160 mg/d) before ablation, and they were responsive to intravenous propranolol; (8) verapamil terminated AT in 26 of 27 cases (96%), and AT was still inducible under verapamil (nonsustained AT) in 3 of the 27 (11%) ( Fig  3D) ; clinical information showed that 8 patients had good response to oral verapamil before ablation (240 to 320 mg/d), and they were responsive to intravenous verapamil; (9) Valsalva maneuver and carotid sinus pressure terminated AT in only 2 of 27 cases (7.4%), with shortening of action potential duration (from 170 or 160 to 150 or 145 milliseconds, respectively); (10) edrophonium infusion terminated AT in only 2 of 18 cases (11%), and in 17 of the 18 (94%), AT (sustained AT) was still inducible under edrophonium; and (11) aminophylline and atropine could reverse the effects of dipyridamole and edrophonium, respectively. Group 2: Automatic AT Seven patients (see Tables 1 and 3) had inducible automatic AT, with minimal AT cycle length ranging from 320 to 400 milliseconds (mean, 356±33 milliseconds); exit sites of AT were in the right atria in 4 (4 [44%] of the 9 in the septal area). None of the 9 patients had multiple AT, and the mean AT cycle length was 396±66 milliseconds. They were identified by the following characteristics: (1) initiation of AT was reproducible with rapid atrial pacing in 9 patients, and AT could also be initiated by atrial extrastimuli under isoproterenol in only 1 of the 9 patients. Isoproterenol alone initiated AT in 1 patient. In addition, AT usually demonstrated cycle length dependence, and its initiation was dependent on achieving a critical range of atrial pacing cycle lengths; (2) delayed afterdepolarization was more prominent in the recordings of monophasic action potential just before onset of AT (Fig 8) , and recordings from the areas remote from the exit site did not show any afterdepolarization; (3) termination of AT was reproducible with programmed stimulation; (4) entrainment was not found, but overdrive suppression and overdrive termination were demonstrated; (5) there were two types of resetting response patterns (6 of the mixed type of AT, with a resetting interval of 160±56 milliseconds, and 2 of the increasing type, with a resetting interval of 75±7 milliseconds); (6) adenosine terminated AT in all cases; the minimal effective dose was 23.3±15.2 gg/kg (lower than group 1, but without statistical significance, P>.05), the time required to terminate AT shortened progressively when the adenosine dose increased (P<.05 at 60, 120, and 240 ,ug/kg compared with 15 gg/kg) (Fig 6) , and the minimal shortening of APD90 just before termination of AT was 16+4 milliseconds (n=8, P<.01); (7) dipyridamole (termination time, 0.7±0.2 minutes), propranolol, verapamil, Valsalva maneuvers, carotid sinus pressure (termination time, 5+2 seconds; shortening of APDg, 15±5 milliseconds, n=8, P<.01), and edrophonium terminated AT in all group 3 patients; (8) under dipyridamole, propranolol, verapamil, and edrophonium infusion, AT (nonsustained) was inducible in 4 (44%), 6 (66%), 0 (0%), and 4 (44%) of the 9 patients with AT, respectively; clinical information showed that 2 patients had good response to oral verapamil (240 to 320 mg/d), 2 patients had good response to oral propranolol (80 to 160 mg/d) before ablation, and AT was not inducible after intravenous verapamil and propranolol, respectively; and (9) aminophylline and atropine could reverse the effects of dipyridamole and edrophonium in all patients. In 4 patients, the amplitude of delayed afterdepolarization on the last beat of nonsustained AT decreased significantly after dipyridamole (-2.5±0.2 mV, P<.05 compared with the first initiating afterdepolarization) (Fig 8) .
Radiofrequency Ablation of Various ATs
Thirty-four patients with 41 cases of AT received radiofrequency ablation therapy. The endocardial mapping data, biophysical characteristics of radiofrequency energy, and results of radiofrequency ablation are shown in Table 5 . The earliest atrial activation time preceding surface ECG P waves and number of test pulses for successful ablation were similar in the three groups. Radiofrequency ablation failed in 2 patients with AT related to triggered activity, and 1 of them had successful ablation in the secondary ablation session. During the follow-up period (2 to 37 months; mean, 18±4 months), 2 patients had recurrent AT and received successful secondary ablation sessions without later recurrence. None of the patients had any procedure-related complication.
Discussion
In this study, the major findings of electropharmacological characteristics are summarized in Table 6 : (1) programmed stimulation could not initiate or terminate AT in patients with automatic AT; (2) induction of AT related to triggered activity is usually dependent on achievement of critical pacing cycle length with increasing amplitude of delayed afterdepolarization; (3) entrainment phenomenon and slow conduction were demonstrable only in patients with reentrant AT; (4) overdrive suppression after atrial pacing was demonstrable in AT related to automaticity and triggered activity; (5) resetting response patterns were similar in the three groups; (6) verapamil, adenosine, and acetylcholine (endogenous and exogenous) were not effective in terminating automatic AT; (7) group 1, patient 11) . The earliest atrial activation was near the coronary sinus orifice (OCS). PCS indicates proximal coronary sinus. A and B, AT cycle length of 330 milliseconds; rapid pacing (S1S1) was performed from the high right atrium (HRA) with a cycle length of 310 and 290 milliseconds, respectively. Constant fusions in different pacing rates were demonstrated (oblique arrows). The morphology of the last paced beat (vertical arrow) was similar to the spontaneous AT beat (star). Please note the local electrogram in the His bundle area (HBE). The atrial activation electrograms were different between pacing (oblique arrow) and AT (vertical arrow and star). It is possible that the atrial activation in the HBE during pacing was from antidromic activation and the last entrained beat (vertical arrow) was from orthodromic activation. Furthermore, conduction time from the HRA to OCS was progressively prolonged. A decremental conduction area (slow conduction area) would be present in the orthodromic activation direction (E). C, Atrial extrastimuli (coupling interval, 370 milliseconds) initiate two atrial reentrant echoes with a longer cycle length (360 milliseconds) after intravenous propranolol. D, Initiation of one atrial reentrant echo after intravenous verapamil. E, The antidromic Response to programmed stimulation and electropharmacological study suggested that the mechanisms of tachycardia included reentry, triggered activity, and catecholamine-mediated automaticity. Tachycardia resulting from triggered activity related to delayed afterdepolarizations has been identified and characterized in both animal and human studies.14-'8 Within a critical range of cycle lengths, delayed afterdepolarizations may attain threshold and elicit an action potential that, if perpetuated, can lead to a sustained rhythmic activity.14-17 In this study, AT suggestive of triggered activity conformed to some of the electrophysiological features described in isolated tissue preparations. However, differentiation between reentry and triggered activity remains difficult, because both reentry and triggered activity may have similar clinical electrophysiological manifestations despite differences in their basic electrophysiological mechanisms. As demonstrated in this study, reentry and triggered activity could be initiated and terminated by programmed electrical stimulation. The initiation of group 1) . B, Rapid atrial pacing with a cycle length of 410 milliseconds from the area near the exit site of AT. Concealed entrainment pacing mapping was performed; the morphologies of 12-lead P waves were identical during both entrainment pacing and spontaneous AT, and the stimulus-P-wave interval was short (about 30 the present study patients with AT related to triggered activity or automaticity. It might reasonably be expected that some triggered activity met criteria 1 and 2 of manifest entrainment (progressive and constant fusion); however, the first beat after cessation of atrial pacing might approximate the pacing cycle length, or the triggered rhythm might gradually or suddenly terminate. 44 Hence, it appears that some distinctions really existed between triggered and reentrant rhythms regarding the entrainment phenomenon. group 2) . A, Appearance of sinus tachycardia (cycle length, 270 milliseconds) with delayed afterdepolarization (arrow) in the monophasic action potential (MAP) recordings after intravenous isoproterenol. B, AT caused by triggered activity was initiated after rapid atrial pacing (cycle length, 210 milliseconds) and isoproterenol infusion. After the last paced beat, delayed afterdepolarization was followed by AT (arrow). The earliest atrial activation was recorded in the His bundle area (HBE). Oscillation of afterdepolarization rising slope was accompanied by cycle length alternans. C, After intravenous persantin and isoproterenol, 2 AT beats were initiated by triggered activity. The third afterdepolarization showed a less steep rising slope (horizontal arrows) than in the second afterdepolarization, and a smaller amplitude (vertical arrows on the crest of afterdepolarization) than in the first afterdepolarization. D, Termination of AT after intravenous verapamil; sinus rhythm with stable monophasic action potential recordings followed. Afterdepolarization was not found (compared with A). HRA indicates high right atrium; PCS and MCS, proximal and middle coronary sinus, respectively; and OCS, coronary sinus orifice.
Usefulness of Monophasic Action Potential Recording
Monophasic action potentials are extracellularly recorded waveforms that can reproduce the repolarization time course of intracellular action potentials, and this recording technique is suitable for studying local repolarization, bridging the gap between basic and clinical electrophysiology.19 20 During AT, the monophasic action potential showed a regular and repeating wave form with characteristics very similar to that during sinus rhythm. Despite the fast rate, repolarization is always complete between successive depolarizations, and they are separated from each other by a distinct diastolic interval. The possibility that the delayed afterdepolarization and the increasing diastolic slope arose as a result of atrial wall motion or an unstable recording must be excluded, but it seems unlikely. First, the onset of delayed afterdepolarization or increasing diastolic slope in monophasic action potential was earlier than or simultaneous with the onset of the P wave during AT, indicating that the recording site was close to the exit site of AT; second, delayed afterdepolarization and increasing diastolic slope were not recorded from any site remote from the AT focus; third, delayed afterdepolarization and increasing diastolic slope were not found after intravenous verapamil and propranolol, respectively; and fourth, the resting potential from which the first sinus beat after the termination of AT arose was relatively constant, implying a stable recording. These findings demonstrate a close relation between the specific findings from monophasic action potential recording and AT, and they are helpful in differentiating the mechanisms of AT. Study limitations showed that the absolute values of maximal diastolic potential and upstroke velocity of phase 0 (dV/dt) were difficult to obtain in monophasic action potential recording,19 and the recording sites might not be exactly in the reentrant path or exit sites of AT.
Further studies are necessary to learn more about various types of AT. Marked increase in ventilatory drive could in turn attenuate sympathetic nerve activity by activating thoracic stretch receptors.62 Termination of AT with exogenous adenosine could therefore be related to reactive withdrawal of sympathetic nerve traffic. Likewise, the Valsalva maneuver and carotid sinus pressure may terminate AT independent of muscarinic cholinergic receptor activation. These effects might be attributed to a decrease in venous return to the heart with reduction of myocardial stretch.30 If the antiarrhythmic effects of adenosine and vagal maneuvers on AT are related to these latter effects (and not to activation of their respective myocardial receptors and inhibition of adenylate cyclase), then termination of tachycardia with adenosine and vagal maneuvers may be unrelated to specific cellular mechanisms of AT such as adenosine and acetylcholine-sensitive potassium channel and cAMP-mediated triggered activity. Therefore, the response of AT to endogenous adenosine and acetylcholine (both inhibit adenylate cyclase through binding to their respective receptor) was studied to circumvent both autonomic and noncardiac receptor effects. In this study, intravenous dipyridamole at the dose used elevated endogenous interstitial adenosine levels but probably had minimal clinical effect on reflex autonomic nervous activity. This is supported by findings of minimal effect on systolic or diastolic blood pressure during AT (<10 mm Hg) without acceleration of the rate of AT. Aminophylline, an adenosine receptor antagonist, completely reversed the antiarrhythmic effects of dipyridamole, resulting in reemergence of sustained AT. Although methylxanthines can also inhibit phosphodiesterase and stimulate release of norepinephrine from nerve terminals and the adrenal medulla, these effects occur at levels at least 20-fold greater than that required to antagonize the adenosine A1 receptor.63 Therefore, the antiarrhythmic effects of dipyridamole on AT in this study are related to its elevation of endogenous adenosine and its effect at the myocardial adenosine A, receptor. Previous studies of ventricular myocytes showed that adenosine had no effect on quinidineinduced early afterdepolarizations or ouabain-induced cAMP-independent delayed afterdepolarization.64 Catecholamines may also mediate triggered activity through a mechanism that was independent of cAMP and could enhance a-receptor effects.65 However, adenosine did not antagonize the a-receptor-mediated effects.66 These data as well as the results of this study suggested that termination of AT related to triggered activity by adenosine is probably a mechanism-specific response related to adenosine. This study showed that the cholinesterase inhibitor edrophonium could terminate AT, and the reversal of edrophonium's effects could be demonstrated by blocking the muscarinic cholinergic receptor with atropine. These data were consistent with a muscarinic cholinergic receptor-mediated from our laboratory.23,25The proposed mechanism was process for vagal termination of AT related to triggered activity.
Reentrant AT
Haines and DiMarco12 found that adenosine was not effective in 13 '76 also found that adenosine (10 ,umol/L) could significantly activate the adenosine-sensitive potassium channel without any measurable effect on calcium current; however, adenosine could reduce calcium current and inisoproterenol. In isolated preparations, adenosine transiently suppressed but did not terminate enhanced automaticity, and adenosine had no effect on abnormal automaticity whether or not it was dependent on catecholamine stimulation.77 In this study, a large dose of adenosine only transiently suppressed AT, and a rebound effect with acceleration of AT rate followed. Vagal maneuvers also showed an effect similar to that of adenosine on automatic AT. Because of limitations of the study technique, a detailed and definable mechanism governing normal or abnormal automaticity and the effects of adenosine and vagal maneuvers on automatic AT were not clear.
Radiofrequency Ablation of Atrial Tachycardia
Poor control of AT may ultimately necessitate aggressive therapy. Antiarrhythmic drugs have shown shortterm effects, but the long-term outcome has been disappointing as a result of recurrent arrhythmia or drug side effects. In this study, oral medication before ablation varied widely among the study patients, and a definite relation between oral and intravenous drug effects will be obtained after study of a larger group. Direct-current ablation carried a potential risk of perforation through the relatively thin atrial wall. Radiofrequency lesions at the atrial level have been shown to produce transmural necrosis that heals with a wellorganized fibrous scar and have not been associated with significant risk for either early or late perforation.78 Radiofrequency ablation is also free of the barotrauma and catheter fling seen with direct-current ablation, further decreasing the likelihood of acute atrial trauma. 78 In patients with reentrant AT, concealed entrainment with a long stimulus-to-P-wave interval was demonstrated during pacing near the earliest activation site, and a short stimulus-to-P-wave interval was demonstrated during pacing at the exit site, suggesting the existence of an area of slow conduction. Radiofrequency energy delivered to the exit site could eliminate AT. Furthermore, Feld et a179 reported that a combination of endocardial activation mapping and entrainment pace mapping could determine a critical area for radiofrequency ablation of common-type atrial flutter. In patients with AT not related to reentry, a combination of pace mapping and finding of earliest atrial activation would be suitable. Furthermore, the success rate and radiofrequency pulse number were similar in the three groups.
In the present study, fluoroscopy and procedure times were similar to the times reported for radio frequency ablation of accessory atrioventricular pathways or slow atrioventricular nodal pathways in our laboratory. 39 Innovations in mapping catheter design may permit faster simultaneous mapping of multiple atrial sites; more experience with this ablation technique and laboratory equipment available with the capacity for pulsed fluoroscopy at slow frame rates will shorten procedure time and reduce radiation exposure time for both the patient and operator. Unlike the accessory pathways and slow atrioventricular nodal pathways, accurate localization of an atrial focus must involve three-dimensional mapping and is further confounded by the absence of reliable electrogram markers (such as accessory pathway or slow atrioventricular nodal pathway activation potentials), apart from local activation hibit funny current when the currents were enhanced by time and entrainment pace mapping. Despite these difficulties, radiofrequency ablation was successful in 33 of 34 patients, who remained in sinus rhythm without medications. Radiofrequency ablation of atrial tissue could be recommended as an alternative to medication or surgery in patients with various types of AT.
Limitations
Several study limitations were noted. First, this institution had a predominance of male and older patients in the study population. Second, resetting response patterns from different pacing sites might obtain different results. Third, endogenous interstitial adenosine and acetylcholine levels were not measured, and total autonomic blockade was not performed in this study. It is possible that both autonomic and noncardiac receptor effects were not really circumvented. Fourth, the differential diagnosis between automatic AT with exit site near the sinus node and paroxysmal sinus tachycardia deserves further study.
Conclusions
This study demonstrated the diverse mechanisms of AT in adult patients; the major mechanism was reentry. However, the serial electropharmacological responses were not obtained in the pediatric patients. Although radiofrequency ablation could achieve a high success and low recurrence rate in patients with various types of AT, further detailed study about the electropharmacological mechanism will be necessary.
